Left Menu
Development News Edition

Researchers discover new strategy to treat brain cancer patients

A team of investigators has uncovered a potentially promising strategy to target brain tumours -- isocitrate dehydrogenase (IDH) genes, which are the most common brain tumours diagnosed in younger adults aged 18 to 45 years.

ANI | Washington DC | Updated: 01-07-2020 12:50 IST | Created: 01-07-2020 12:42 IST
Researchers discover new strategy to treat brain cancer patients
Representative Image. Image Credit: ANI

A team of investigators has uncovered a potentially promising strategy to target brain tumors isocitrate dehydrogenase (IDH) genes, which are the most common brain tumors diagnosed in younger adults aged 18 to 45 years. Led by investigators at Massachusetts General Hospital, the finding of their study are published in Cancer Discovery, a journal of the American Association for Cancer Research.

Prior work by the group, led by Mass General's Daniel Cahill, MD, Ph.D., Hiroaki Wakimoto, MD, Ph.D., and Julie Miller, MD, Ph.D., revealed that IDH mutant gliomas have a metabolic weakness making them especially susceptible to treatments that lower NAD+ levels, a ubiquitous and vital metabolic molecule commonly thought of as the "currency of metabolism" in cells. Also, previous work by other researchers found that chemotherapy activates an enzyme that stimulates NAD+ molecules to join together to make poly(ADP-ribose), or PAR, a key DNA damage signal. This PAR signal is a known susceptibility in IDH mutant gliomas.

Researchers also discovered that activation of the enzyme by chemotherapy causes available NAD+ to be critically depleted for the production of PAR in IDH mutant glioma cells, but not normal cells. These findings indicated that maintaining high PAR levels (and low NAD+ levels), in combination with chemotherapy, may uniquely target IDH mutant glioma cells. Considering this, Hiroaki Nagashima, MD, Ph.D., research fellow, and lead author, devised a new treatment strategy and tested it in tumor cells and animal models.

"We found that maximum effectiveness was achieved by combining two agents: temozolomide, the chemotherapy most commonly used to treat patients with IDH mutant gliomas, with a drug that blocks PAR breakdown, known as a PAR glycohydrolase inhibitor," said Dr. Cahill, a Neurosurgical Oncologist at Mass General and an Associate Professor of Neurosurgery at Harvard Medical School. "We showed, for the first time, that PAR glycohydrolase inhibitors can be used to enhance the effectiveness of chemotherapy in tumors with metabolic weaknesses in the NAD+ pathway," said Dr. Wakimoto, an Associate Professor of Neurosurgery at Harvard Medical School.

Dr. Miller, an Instructor in Neurology and a Neuro-Oncologist at Mass General who treats patients with IDH mutant glioma, noted that PAR glycohydrolase inhibitors are a newly-emerging class of drugs. "The long-term significance is that, based on our findings, they could be tested in individuals with IDH mutant gliomas, with a goal of hopefully improving outcomes in these patients," she said.


TRENDING

OPINION / BLOG / INTERVIEW

Why COVID-19 is unstoppable in USA despite it being ranked at the top of GHS Index?

Several worst-hit countries such as Italy, France, Spain, the UK, Canada, and Russia have peaked COVID-19 cases in April. Almost all of them have gradually flattened the curve. However, the USA is setting new daily records of infections tha...

COVID-19 seems cooking biggest ever global scam

The increasing number of corruption cases on COVID-19 funds from throughout the world and involvement of high profile persons indicate that the countries cant ignore corruption in their pandemic response programs. This has generated the nee...

Health Management Information Systems lack holistic, integrated, and pandemic resilient character

Being a part of the United Nations system, the World Health Organization WHO deserves its share of rebuke for its alleged failure issue COVID-19 health emergency alerts on appropriate time. However, the pandemic has also exposed loopholes i...

Pride in the time of coronavirus: a welcome move online?

This year is different in many ways not least as celebrations are also taking place against the dramatic backdrop of a global health crisis and a resurgence in grassroots activism following the death of George Floyd in Minneapolis. ...

Videos

Latest News

Hong Kongers stand in long queues on second day of primary elections

Long queues reappeared outside polling stations across Hong Kong on Sunday morning as residents flocked to cast their votes in a weekend primary held by the opposition camp for the upcoming Legislative Council elections, a day after it drew...

Turkey revokes experience requirement for central bank deputy governor

Turkey has revoked a requirement that central bank deputy governors have 10 years prior experience and dropped a rule that banks set aside 20 of annual profit, the official gazette showed on Sunday. According to a decree published on the ga...

COVID: UP CM says all markets be sanitised on weekends

Uttar Pradesh Chief Minister Yogi Adityanath on Sunday directed officials to carry out a special cleanliness and sanitisation drive in all markets on weekends when all shops will be shut to contain the spread of COVID-19. He said all indust...

New team of BJP office-bearers likely to be announced soon

Several new faces are likely to enter the BJP parliamentary board, the highest body of the party, as its president J P Nadda appears set to announce a fresh team of office-bearers soon. Nadda had taken over as party president in January and...

Give Feedback